Private Equity Transactions in Healthcare: Stark, AKS and Other Compliance Challenges

Structuring Purchase Price, Restrictive Covenants, Indemnities, Equity Rollovers and More

Recording of a 90-minute CLE webinar with Q&A

Conducted on Thursday, November 16, 2017

Recorded event now available

or call 1-800-926-7926
Program Materials

This CLE webinar will provide guidance to counsel involved in structuring private equity transactions in the healthcare arena. The panel will discuss the nuts and bolts of structuring the transaction, including purchase price considerations, tax structures, deal terms and indemnities. The panel will also address approaches to overcome regulatory problems.


Private equity firms play an active role in healthcare deals, investing $29 billion in the first quarter of 2017. The healthcare sector is seeking and drawing the attention of private equity firms for investment in long-term care, urgent care, surgery centers, health IT companies, behavioral health, and dental practices. On July 24, 2017, WebMD Health Corp. announced it agreed to be bought by private equity firm KKR & Co. in a deal valued at about $2.8 billion.

Counsel must consider several factors when structuring private equity transactions, including purchase price issues, deal structure and tax implications, as well as Stark, Anti-Kickback Statute, and other regulatory issues.

Listen as our authoritative panel examines the nuts and bolts of healthcare private equity transactions. The panel will discuss purchase price considerations, tax structures, deal terms and indemnities. The panel will also provide guidance for addressing regulatory issues in healthcare private equity transactions.



  1. Purchase price considerations
  2. Deal and tax structuring and the impact of legacy tax structures and the corporate practice of medicine
  3. Common deal terms and indemnities
  4. Regulatory issues
  5. Restrictive covenants
  6. Equity rollover considerations and structuring of governance, puts/calls, and tag-along/drag-along considerations


The panel will review these and other key issues:

  • What hurdles do counsel encounter when involving private equity firms in healthcare transactions?
  • What factors should counsel keep in mind when determining price and deal structure?
  • What best practices should counsel employ to ensure regulatory compliance in a healthcare private equity transaction?


Riddle, John
John C. Riddle

Managing Director
Brown Gibbons Lang & Company

Mr. Riddle leads the firm's investment banking activities in Healthcare and Life Sciences. He has over twenty years...  |  Read More

Strode, Roger
Roger D. Strode

Foley & Lardner

Mr. Strode's practice focuses on health care business transactions, including mergers, acquisitions, corporate...  |  Read More

Other Formats
— Anytime, Anywhere

Strafford will process CLE credit for one person on each recording. All formats include program handouts. To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Video